Orient Pharma Co., Ltd. (4166.TWO)

TWD 37.1

(-2.5%)

EBITDA Summary of Orient Pharma Co., Ltd.

  • Orient Pharma Co., Ltd.'s latest annual EBITDA in 2023 was 172.39 Million TWD , up 397.16% from previous year.
  • Orient Pharma Co., Ltd.'s latest quarterly EBITDA in 2024 Q2 was 88.75 Million TWD , down 0.0% from previous quarter.
  • Orient Pharma Co., Ltd. reported an annual EBITDA of 35.36 Million TWD in 2022, up 190.19% from previous year.
  • Orient Pharma Co., Ltd. reported an annual EBITDA of -39.21 Million TWD in 2021, up 58.15% from previous year.
  • Orient Pharma Co., Ltd. reported a quarterly EBITDA of 88.75 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • Orient Pharma Co., Ltd. reported a quarterly EBITDA of 41.25 Million TWD for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Orient Pharma Co., Ltd. (2023 - 2019)

Historical Annual EBITDA of Orient Pharma Co., Ltd. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 172.39 Million TWD 397.16%
2022 35.36 Million TWD 190.19%
2021 -39.21 Million TWD 58.15%
2020 -93.7 Million TWD 37.81%
2019 -130.33 Million TWD 0.0%

Peer EBITDA Comparison of Orient Pharma Co., Ltd.

Name EBITDA EBITDA Difference
Allied Biotech Corporation 204.79 Million TWD 15.819%
GeneFerm Biotechnology Co., Ltd. 231.09 Million TWD 25.4%
Easywell Biomedicals, Inc. -85.5 Million TWD 301.629%
TTY Biopharm Company Limited 1.52 Billion TWD 88.691%
Synmosa Biopharma Corporation 1 Billion TWD 82.91%
Orient EuroPharma Co., Ltd. 582.93 Million TWD 70.426%
Center Laboratories, Inc. -175.17 Million TWD 198.416%
Tien Liang BioTech Co., Ltd. 31.04 Million TWD -455.253%
InnoPharmax Inc. -62.12 Million TWD 377.519%
Johnson Chemical Pharmaceutical Works Co., Ltd. 126.67 Million TWD -36.089%
Excelsior Biopharma Inc. -29.36 Million TWD 686.996%
DV Biomed Co., Ltd. 407.64 Million TWD 57.709%
Foresee Pharmaceuticals Co., Ltd. -912.16 Million TWD 118.9%
Handa Pharmaceuticals, Inc. 802.78 Million TWD 78.525%
UniPharma Co., Ltd. -16.25 Million TWD 1160.631%
Anxo Pharmaceutical Co., Ltd. 131.31 Million TWD -31.289%
Alar Pharmaceuticals Inc. 394.52 Million TWD 56.303%
Winston Medical Supply Co., Ltd. 228.32 Million TWD 24.496%
Mercury Biopharmaceutical Corporation -39.03 Million TWD 541.653%
Bioray Biotech Co., Ltd 12.13 Million TWD -1320.643%
TSH Biopharm Corporation Limited 99.35 Million TWD -73.523%